Monte Rosa Therapeutics, Inc. (GLUE)
13.78
-0.52
(-3.67%)
USD |
NASDAQ |
Aug 24, 16:00
13.77
0.00 (0.00%)
After-Hours: 20:00
Monte Rosa Therapeutics Total Liabilities (Quarterly) : 203.88M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 203.88M |
| March 31, 2026 | 214.51M |
| December 31, 2025 | 215.60M |
| September 30, 2025 | 214.00M |
| June 30, 2025 | 91.51M |
| March 31, 2025 | 118.04M |
| December 31, 2024 | 215.80M |
| September 30, 2024 | 109.62M |
| June 30, 2024 | 119.44M |
| March 31, 2024 | 114.23M |
| December 31, 2023 | 124.50M |
| September 30, 2023 | 67.58M |
| Date | Value |
|---|---|
| June 30, 2023 | 64.96M |
| March 31, 2023 | 65.30M |
| December 31, 2022 | 70.98M |
| September 30, 2022 | 66.51M |
| June 30, 2022 | 63.01M |
| March 31, 2022 | 20.13M |
| December 31, 2021 | 18.81M |
| September 30, 2021 | 14.74M |
| June 30, 2021 | 12.26M |
| March 31, 2021 | 241.22M |
| December 31, 2020 | 98.11M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nurix Therapeutics, Inc. | 132.91M |
| Gilead Sciences, Inc. | 37.62B |
| Ironwood Pharmaceuticals, Inc. | 446.97M |
| Capricor Therapeutics, Inc. | 122.52M |
| Cue Biopharma, Inc. | 28.40M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 691.16M |
| Shareholders Equity (Quarterly) | 487.28M |
| Debt to Equity Ratio | 0.078 |
| Current Ratio | 10.58 |
| Net Debt Paydown Yield | 0.04% |